126 related articles for article (PubMed ID: 25853942)
1. [Binocular Fluocinolone Acetonide Intravitreal Implant for Therapy-Resistant Diabetic Maculopathy].
Linz K; Auffarth GU; Kretz FT
Klin Monbl Augenheilkd; 2015 Oct; 232(10):1208-12. PubMed ID: 25853942
[No Abstract] [Full Text] [Related]
2. Fluocinolone Acetonide Intravitreal Implant in the Visual Axis.
Moisseiev E; Morse LS
JAMA Ophthalmol; 2016 Sep; 134(9):1067-8. PubMed ID: 27367921
[No Abstract] [Full Text] [Related]
3. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
Soubrane G; Behar-Cohen F
J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review.
Massa H; Nagar AM; Vergados A; Dadoukis P; Patra S; Panos GD
J Int Med Res; 2019 Jan; 47(1):31-43. PubMed ID: 30556449
[TBL] [Abstract][Full Text] [Related]
5. Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report.
Wasielica-Poslednik J; Pfeiffer N; Gericke A
J Med Case Rep; 2019 Jan; 13(1):21. PubMed ID: 30674351
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors for visual outcome after intravitreal drug therapy for chronic diabetic macular oedema].
Guthoff R; Schrader W; Hennemann K; Meigen T; Göbel W
Klin Monbl Augenheilkd; 2011 May; 228(5):468-72. PubMed ID: 20597042
[TBL] [Abstract][Full Text] [Related]
7. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
Pearson PA; Comstock TL; Ip M; Callanan D; Morse LS; Ashton P; Levy B; Mann ES; Eliott D
Ophthalmology; 2011 Aug; 118(8):1580-7. PubMed ID: 21813090
[TBL] [Abstract][Full Text] [Related]
8. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Campochiaro PA; Brown DM; Pearson A; Ciulla T; Boyer D; Holz FG; Tolentino M; Gupta A; Duarte L; Madreperla S; Gonder J; Kapik B; Billman K; Kane FE;
Ophthalmology; 2011 Apr; 118(4):626-635.e2. PubMed ID: 21459216
[TBL] [Abstract][Full Text] [Related]
9. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
[TBL] [Abstract][Full Text] [Related]
10. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
11. Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Cunha-Vaz J; Ashton P; Iezzi R; Campochiaro P; Dugel PU; Holz FG; Weber M; Danis RP; Kuppermann BD; Bailey C; Billman K; Kapik B; Kane F; Green K;
Ophthalmology; 2014 Oct; 121(10):1892-903. PubMed ID: 24935282
[TBL] [Abstract][Full Text] [Related]
12. Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.
Drugs R D; 2005; 6(2):116-9. PubMed ID: 15777105
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of a fluocinolone acetonide intravitreal implant for patients with DME based on the FAME study.
Cutino A; Green K; Kendall R; Moore PT; Zachary C
Am J Manag Care; 2015 Jan; 21(4 Suppl):S63-72. PubMed ID: 25734663
[TBL] [Abstract][Full Text] [Related]
14. Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant.
Seth RK; Gaudio PA
Ocul Immunol Inflamm; 2008; 16(3):103-5. PubMed ID: 18569797
[TBL] [Abstract][Full Text] [Related]
15. Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
Taban M; Lowder CY; Kaiser PK
Retina; 2008 Oct; 28(9):1280-8. PubMed ID: 18628725
[No Abstract] [Full Text] [Related]
16. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
17. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of possible prognostic factors for the course of visual acuity after intravitreal ttriamconolone acetonide].
Schmidt B; Krummenauer F; Lösche CC
Klin Monbl Augenheilkd; 2012 Jan; 229(1):56-61. PubMed ID: 21837585
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis.
Park UC; Kim SJ; Yu HG
Ocul Immunol Inflamm; 2011 Aug; 19(4):282-3. PubMed ID: 21770807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
